Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes

被引:21
|
作者
Taya, Naohiro [1 ]
Katakami, Naoto [1 ]
Mita, Tomoya [2 ]
Okada, Yosuke [3 ]
Wakasugi, Satomi [2 ]
Yoshii, Hidenori [4 ]
Shiraiwa, Toshihiko [5 ]
Otsuka, Akihito [6 ]
Umayahara, Yutaka [7 ]
Ryomoto, Kayoko [8 ]
Hatazaki, Masahiro [9 ]
Yasuda, Tetsuyuki [10 ]
Yamamoto, Tsunehiko [11 ]
Gosho, Masahiko [12 ]
Shimomura, Iichiro [1 ]
Watada, Hirotaka [2 ]
机构
[1] Osaka Univ, Dept Metab Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[3] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka, Japan
[4] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Med Diabetol & Endocrinol, Koto Ku, 3-3-20 Shinsuna, Tokyo, Japan
[5] Shiraiwa Med Clin, 4-10-24 Houzenji, Kashiwara, Osaka, Japan
[6] Kawasaki Hosp, Dept Internal Med, Hyogo Ku, 3-3-1 Higashiyamacho, Kobe, Hyogo, Japan
[7] Osaka Gen Med Ctr, Dept Diabet & Endocrinol, Sumiyoshi Ku, 3-1-56 Bandaihigashi, Osaka, Osaka, Japan
[8] Osaka Rosai Hosp, Ctr Diabet Mellitus, Kita Ku, 1179-3 Nagasonecho, Sakai, Osaka, Japan
[9] Japan Community Hlth Care Org Osaka Hosp, Dept Internal Med, Fukushima Ku, 4-2-78 Fukushima, Osaka, Osaka, Japan
[10] Osaka Police Hosp, Dept Diabet & Endocrinol, Tennoji Ku, 10-31 Kitayamacho, Osaka, Osaka, Japan
[11] Kansai Rosai Hosp, Diabet & Endocrinol, 3-1-69 Inabaso, Amagasaki, Hyogo, Japan
[12] Univ Tsukuba, Fac Med, Dept Biostat, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan
关键词
Type; 2; diabetes; Glucose variability; Continuous glucose monitoring; Intima-media thickness; Gray-scale median; Tissue characteristics; CORONARY PLAQUE VULNERABILITY; CARDIOVASCULAR RISK-FACTORS; PROTEIN-KINASE-C; GLYCEMIC VARIABILITY; OXIDATIVE STRESS; SUBCLINICAL ATHEROSCLEROSIS; ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; PREDICTION; EVENTS;
D O I
10.1186/s12933-021-01288-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The association between glucose variability and the progression of atherosclerosis is not completely understood. We aimed to evaluate the associations of glucose variability with the progression of atherosclerosis in the early stages. Methods We conducted a cross-sectional analysis to investigate the associations of glucose variability, assessed by continuous glucose monitoring, with intima-media thickness (IMT) and gray-scale median (GSM) of the carotid arteries, which are different indicators for the progression of atherosclerosis. We used baseline data from a hospital-based multicenter prospective observational cohort study among Japanese patients with type 2 diabetes without a history of cardiovascular diseases aged between 30 and 80 years. Continuous glucose monitoring was performed by Freestyle Libre Pro, and glucose levels obtained every 15 min for a maximum of eight days were used to calculate the metrics of glucose variability. IMT and GSM were evaluated by ultrasonography, and the former indicates thickening of intima-media complex in the carotid artery wall, while the latter indicates tissue characteristics. Results Among 600 study participants (age: 64.9 +/- 9.2 (mean +/- SD) years; 63.2%: men; HbA1c: 7.0 +/- 0.8%), participants with a larger intra- and inter-day glucose variability had a lower GSM and most of these associations were statistically significant. No trend based on glucose variability was shown regarding IMT. Standard deviation of glucose (regression coefficient, beta = - 5.822; 95% CI - 8.875 to - 2.768, P < 0.001), glucose coefficient of variation (beta = - 0.418; - 0.685 to - 0.151, P = 0.002), mean amplitude of glycemic excursion (beta = - 1.689; - 2.567 to - 0.811, P < 0.001), mean of daily differences (beta = - 6.500; - 9.758 to - 3.241, P < 0.001), and interquartile range (beta = - 4.289; - 6.964 to - 1.614, P = 0.002) had a statistically significant association with mean-GSM after adjustment for conventional cardiovascular risk factors, including HbA1c. No metrics of glucose variability had a statistically significant association with IMT. Conclusions Continuous glucose monitoring-assessed glucose variability was associated with the tissue characteristics of the carotid artery wall in type 2 diabetes patients without cardiovascular diseases.
引用
收藏
页数:15
相关论文
共 48 条
  • [41] Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study
    Vergani, Michela
    Borella, Nicolo Diego
    Rizzo, Mariangela
    Conti, Matteo
    Perra, Silvia
    Bianconi, Eleonora
    Sani, Elena
    Csermely, Alessandro
    Grespan, Elisabetta
    Targher, Giovanni
    Perseghin, Gianluca
    Mantovani, Alessandro
    Ciardullo, Stefano
    DIABETES OBESITY & METABOLISM, 2025, : 3201 - 3211
  • [42] Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study
    Nishimura, R.
    Osonoi, T.
    Kanada, S.
    Jinnouchi, H.
    Sugio, K.
    Omiya, H.
    Ubukata, M.
    Sakai, S.
    Samukawa, Y.
    DIABETES OBESITY & METABOLISM, 2015, 17 (08) : 800 - 804
  • [43] Time in range assessed by capillary blood glucose in relation to insulin sensitivity and β-cell function in patients with type 2 diabetes mellitus: A cross-sectional study in China
    Ye, Jingwen
    Deng, Jiajin
    Liang, Weiqiang
    Luo, Haizhao
    Mei, Wen
    Liu, Lei
    Wang, Mingzhu
    Shu, Yi
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (11) : 1825 - 1833
  • [44] Predictors of Poor Glycemic Control and Increased Glucose Variability Among Admitted Moderate to Critical COVID-19 Patients with Type 2 Diabetes Mellitus: A Single Center Cross-sectional Study
    Bagos, John Paul Martin
    Mendoza, Erick
    Matawaran, Bien
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (02): : 57 - 64
  • [45] Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-α, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors
    Vazquez-Del Mercado, Monica
    Nunez-Atahualpa, Lourdes
    Figueroa-Sanchez, Mauricio
    Gomez-Banuelos, Eduardo
    Daniel Rocha-Munoz, Alberto
    Teresita Martin-Marquez, Beatriz
    Guadalupe Corona-Sanchez, Esther
    Aurora Martinez-Garcia, Erika
    Macias-Reyes, Hector
    Gonzalez-Lopez, Laura
    Ivan Gamez-Nava, Jorge
    Elena Navarro-Hernandez, Rosa
    Alejandra Nunez-Atahualpa, Maria
    Andrade-Garduno, Javier
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [46] Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study
    Tsai, Pin-Lun
    Lin, Chia-Hung
    Huang, Yu-Yao
    Chen, Hsin-Yun
    Lin, Yi-Hsuan
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2024, 40 (12) : 1086 - 1094
  • [47] Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 studyVergleich der mit einem kontinuierlichen Glukose Monitoring System gemessenen Blutzucker Variabilität bei Patienten mit Typ 2 Diabetes mellitus, die von NPH Insulin auf Insulin Glargin umgestellt wurden – Die COBIN2 Studie
    Denisa Janickova Zdarska
    Milan Kvapil
    Zdenek Rusavy
    Michal Krcma
    Jan Broz
    Bohumila Krivska
    Pavla Kadlecova
    Wiener klinische Wochenschrift, 2014, 126 : 228 - 237
  • [48] Which is better, high-dose metformin monotherapy or low-dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low-dose metformin monotherapy? A randomized, cross-over, continuous glucose monitoring-based pilot study
    Takahashi, Hiroshi
    Nishimura, Rimei
    Tsujino, Daisuke
    Utsunomiya, Kazunori
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 714 - 722